Primary contact

Nuritas combines artificial intelligence and genomics to discover and unlock natural Bioactive Peptides with extraordinary health benefits. The company's proprietary platform targets, predicts and unlocks novel bioactive peptides from everyday food sources. These deliver highly specific, efficient and life-changing health solutions. Nuritas begins the discovery process by precisely defining the health condition and targets it wishes to modulate. It then uses proprietary search tools to identify the characteristics specific to the area of focus. Throughout this process, Nuritas relies on the most up-to-date academic and scientific knowledge to maximise the efficiency and effectiveness of its prediction algorithms. Having begun the discovery process, the company takes advantage of multiple proprietary Artificial Intelligence (AI) algorithms, including deep learning. Using these, Nuritas is now uniquely able to predict which novel food-derived bioactive peptides deliver the pre-determined effect. This cuts out many thousands of hours of trial and error.
Primary contact

Funding 💰

Total €23.9M
Select investors VisVires New Protein, Marc Benioff, NDRC
Last update: May 21, 2018